![]() |
市場調查報告書
商品編碼
1447636
光動力治療設備市場規模- 按產品(二極體雷射、一次性光纖光傳輸設備)、應用(癌症、光化性角化病、痤瘡、牛皮癬)、最終用途(醫院、皮膚科診所)和全球預測,2024 - 2032Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 - 2032 |
在光化性角化症日益普及以及技術快速進步的推動下,2024年至2032年全球光動力治療設備市場將以8.3%的CAGR成長。由於陽光照射等因素,光化性角化症病例不斷增加,對有效治療的需求更高。此外,改進的光源和光敏劑等技術創新正在提高光動力療法的功效和精確度。
隨著迎合這些進步的新產品的推出,市場將經歷大幅成長。例如,2023 年 12 月,Zolar Technologies 和 Oral Science 推出了最新的 Photon EXE 軟式組織二極體雷射。這款新型雷射系統採用緊湊攜帶的設計,配備大型觸控螢幕控制面板,可提高效率和便利性。
光動力治療設備產業根據產品、應用、最終用途和地區進行分類。
在應用方面,由於光化性角化病患病率不斷上升,特別是在陽光照射較多的地區,到2032年,光化性角化病領域的市場收入將實現8.6%的CAGR。光動力療法提供了一種副作用最小的有效治療選擇,推動了其在患者和醫療保健提供者中的採用。隨著意識的不斷增強以及越來越多的人尋求預防性皮膚病治療,光化性角化病治療對光動力治療設備的需求可能會增加
到 2032 年,由於尋求各種皮膚病(包括癌性和癌前病變)的皮膚病治療的人數不斷增加,光動力治療設備市場的皮膚科診所最終用途部分的CAGR可能達到7.9% 。由於光動力療法療效確切且副作用最小,皮膚科診所擴大採用光動力療法,吸引了尋求安全有效治療的患者。人們對皮膚健康和美容手術的日益重視也將推動皮膚科診所對光動力治療設備的需求。
由於癌症盛行率上升、醫療基礎設施的進步以及創新醫療技術的採用增加,亞太地區光動力治療設備產業從 2024 年到 2032 年將實現 8.8% 的CAGR。中國、日本和印度等國家正在展示對研發的大量投資。隨著人口老化的迅速發展以及人們對光動力療法益處的認知不斷增強,該地區的產品需求預計將會上升。
Global Photodynamic Therapy Devices Market will grow at an 8.3% CAGR from 2024 to 2032, fueled by the growing prevalence of actinic keratosis coupled with rapid technological advancements. Actinic keratosis cases are on the rise due to factors like sun exposure, creating a higher demand for effective treatments. Additionally, technological innovations, such as improved light sources and photosensitizers, are enhancing the efficacy and precision of photodynamic therapies.
With new launches for catering to these advancements, the market will experience substantial growth. For instance, in December 2023, Zolar Technologies and Oral Science unveiled the latest Photon EXE soft-tissue diode laser. This new laser system boasts of a compact and portable design, featuring a sizable touchscreen control panel to render enhanced efficiency and convenience.
The photodynamic therapy devices industry is classified based on product, application, end-use, and region.
With respect to application, the market revenue from the actinic keratosis segment will experience 8.6% CAGR up to 2032 due to the rising prevalence of actinic keratosis, especially in regions with high sun exposure. Photodynamic therapy offers an effective treatment option with minimal side effects, driving its adoption among patients and healthcare providers alike. With the growing awareness and more individuals seeking preventative dermatological treatments, the demand for photodynamic therapy devices may rise in actinic keratosis treatment
The dermatology clinics end-use segment in the photodynamic therapy devices market may witness 7.9% CAGR through 2032, propelled by the rising number of individuals seeking dermatological treatments for various skin conditions, including cancerous and precancerous lesions. Dermatology clinics are increasingly adopting photodynamic therapy due to its efficacy and minimal side effects, attracting patients looking for safe and effective treatments. The growing emphasis on skin health and cosmetic procedures will also push the demand for photodynamic therapy devices in dermatology clinics.
Asia Pacific photodynamic therapy devices industry will record an 8.8% CAGR from 2024 to 2032, attributed to the rising cancer prevalence, advancements in healthcare infrastructure, and increased adoption of innovative medical technologies. Countries like China, Japan, and India are showcasing significant investments in research and development. With the burgeoning aging population and the growing awareness of the benefits of photodynamic therapy, the regional product demand is expected to rise.